From July 1, 2022 to September 30, 2022, the company has repurchased 169,090 shares, representing 0.82% for KRW 2,231.28 million. With this, the company has completed the repurchase of 380,360 shares, representing 1.86% for KRW 4,984.4 million under the buyback announced on May 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,150 KRW | -1.71% | -3.36% | -2.18% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.18% | 357M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+28.31% | 12.16B | |
+24.73% | 12.17B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.